ARTICLE | Company News

Trillium Diagnostics, Vivione deal

February 16, 2015 8:00 AM UTC

Diagnostic company Vivione will acquire Trillium for $1.5 million in cash and $4 million in stock. Trillium shareholders are eligible for up to $9.5 million in regulatory milestone payments for up to 64 months after the deal closes. Vivione plans to sell up to 28.5 million shares in a private placement for proceeds of C$10 million ($8 million) to help fund the deal. Vivione expects the deal to close simultaneously with the private placement next quarter. ...